$1.80
0.042.27%
At Close: -
$1.78
-0.02-1.11%
After Hours: 6:25 PM EDT
15 minutes delayed
Fortress Biotech
FBIONASDAQ
want to know what
the Bulls & Bears Say?
Fortress Biotech (NASDAQ:FBIO) Stock, Analyst Ratings, Price Targets, Forecasts
Fortress Biotech Inc has a consensus price target of $6.71 based on the ratings of 10 analysis. The 3 most-recent analyst ratings were released by Roth MKM, Alliance Global Partners, and Roth MKM on May 16, 2024, March 19, 2024, and March 15, 2024, respectively. With an average price target of $8.33 between Roth MKM, Alliance Global Partners, and Roth MKM, there's an implied 368.16% upside for Fortress Biotech Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Roth MKM
Alliance Global Partners
Roth MKM
Benchmark
1calculated from analyst ratings
Analyst Ratings for Fortress Biotech
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Jennifer Kim | — | Reiterates | → Overweight | Get Alert |
| 05/16/2024 | Buy Now | 461.8% | Roth MKM | Jason Wittes | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | 180.9% | Alliance Global Partners | — | → $5 | Initiates | → Buy | Get Alert |
| 03/15/2024 | Buy Now | 461.8% | Roth MKM | Jason Wittes | → $10 | Reinstates | → Buy | Get Alert |
| 11/29/2023 | Buy Now | 742.7% | Roth MKM | Scott Henry | $30 → $15 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 180.9% | Cantor Fitzgerald | Jennifer Kim | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 05/16/2023 | Buy Now | 180.9% | Cantor Fitzgerald | Jennifer Kim | $90 → $75 | Maintains | Overweight | Get Alert |
| 04/06/2023 | Buy Now | 180.9% | Benchmark | Robert Wasserman | → $75 | Reiterates | → Speculative Buy | Get Alert |
| 08/04/2022 | Buy Now | 237.08% | Ladenburg Thalmann | Jeffrey Cohen | → $90 | Initiates | → Buy | Get Alert |
| 07/14/2022 | Buy Now | 237.08% | B. Riley Securities | Mayank Mamtani | $120 → $90 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Fortress Biotech (FBIO) stock?
The latest price target for Fortress Biotech (NASDAQ:FBIO) was reported by Cantor Fitzgerald on June 20, 2024. The analyst firm set a price target for $0.00 expecting FBIO to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fortress Biotech (FBIO)?
The latest analyst rating for Fortress Biotech (NASDAQ:FBIO) was provided by Cantor Fitzgerald, and Fortress Biotech reiterated their overweight rating.
When was the last upgrade for Fortress Biotech (FBIO)?
There is no last upgrade for Fortress Biotech
When was the last downgrade for Fortress Biotech (FBIO)?
There is no last downgrade for Fortress Biotech.
When is the next analyst rating going to be posted or updated for Fortress Biotech (FBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fortress Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fortress Biotech was filed on June 20, 2024 so you should expect the next rating to be made available sometime around June 20, 2025.
Is the Analyst Rating Fortress Biotech (FBIO) correct?
While ratings are subjective and will change, the latest Fortress Biotech (FBIO) rating was a reiterated with a price target of $0.00 to $0.00. The current price Fortress Biotech (FBIO) is trading at is $1.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.